Litcius/Paper detail

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane

Hailin Pang, Jiayue Ouyang, Zengwen Yang, Hong Shang, Guoxin Liang

2023Proceedings of the National Academy of Sciences10 citationsDOIOpen Access PDF

Abstract

The urokinase-type plasminogen activator (uPA) system consists of the proteinase uPA, its receptor (PLAUR/uPAR). Under physiological conditions, uPA and PLAUR are predominantly expressed by blood cells, including neutrophils, monocytes, and macrophages, and play important roles in cell activation, adhesion, migration, and extravasation. Here, we report that PLAUR, which is highly expressed in macrophages and dendritic cells (DCs) but hardly expressed in CD4 + T cells, inhibits the release of HIV-1 progeny virions from the cell membrane. Silencing PLAUR markedly enhanced the transmission of HIV-1 in macrophages and DCs. We further demonstrated that PLAUR is localized at the cell membrane to block the release of HIV-1 virions. Interestingly, we found that uPA compromises the PLAUR-mediated inhibition to slightly enhance HIV-1 production in primary macrophages and DCs. In the absence of PLAUR, this enhanced effect induced by uPA is abrogated. In conclusion, PLAUR is a new anti-HIV-1 protein produced in both macrophages and DCs where it inhibits HIV-1 transmission. This discovery may provide a novel therapeutic target for combating HIV.

Topics & Concepts

Urokinase receptorCell biologyReceptorCellBiologyCell surface receptorActivator (genetics)Plasminogen activatorChemistryBiochemistryGeneticsHIV Research and TreatmentMosquito-borne diseases and controlComplement system in diseases